Highly sulfated chondroitin sulfates, a novel class of prognostic biomarkers in ovarian cancer tissue

Gynecologic Oncology

Volumn 127, Issue 1, 2012, Pages 202-209

  Vallen, Myrtille J E ^a,b   Massuger, Leon F A G ^b   Ten Dam, Gerdy B ^a,b   Bulten, Johan ^b   Van Kuppevelt, Toin H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biomarkers; CHONDROITIN sulfate; GD3G7; Glycosaminoglycans; Ovarian cancer

Indexed keywords

4,6 DISULFATED CHONDROITIN SULFATE; BIOLOGICAL MARKER; CA 125 ANTIGEN; CHONDROITIN SULFATE; EPITOPE; GLYCOSAMINOGLYCAN; MONOCLONAL ANTIBODY KI 67; PLATINUM DERIVATIVE; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BENIGN TUMOR; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CYTOREDUCTIVE SURGERY; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN MOTIF; STROMA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CHONDROITIN SULFATES; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865684271     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.06.022     Document Type: Article

References (34)

1. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
3. A.P. Heintz, F. Odicino, P. Maisonneuve, M.A. Quinn, J.L. Benedet, and W.T. Creasman Carcinoma of the ovary. FIGO 6th annual report on the results of treatment in gynecological cancer Int J Gynaecol Obstet 95 Suppl. 1 2006 S161 S192
4. S. Cattaruzza, P.A. Nicolosi, and R. Perris Proteoglycans in the control of tumor growth and metastasis formation Connect Tissue Res 49 2008 225 229
5. R.V. Iozzo, and R.D. Sanderson Proteoglycans in cancer biology, tumor microenvironment and angiogenesis J Cell mol Med 15 5 2011 1013 1031
6. Y. Wegrowski, and F.X. Maquart Involvement of stromal proteoglycans in tumour progression Crit Rev Oncol Hematol 49 2004 259 268
7. D. Kalathas, D.A. Theocharis, D. Bounias, D. Kyriakopoulou, N. Papageorgakopoulou, and M.S. Stavropoulos Alterations of glycosaminoglycan disaccharide content and composition in colorectal cancer: structural and expressional studies Oncol Rep 22 2009 369 375
8. A.D. Theocharis, D.H. Vynios, N. Papageorgakopoulou, S.S. Skandalis, and D.A. Theocharis Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma Int J Biochem Cell Biol 35 2003 376 390
9. D.H. Vynios, D.A. Theocharis, N. Papageorgakopoulou, T.A. Papadas, N.S. Mastronikolis, and P.D. Goumas Biochemical changes of extracellular proteoglycans in squamous cell laryngeal carcinoma Connect Tissue Res 49 2008 239 243
10. G.B. Ten Dam, E.M. van de Westerlo, A. Purushothaman, R.V. Stan, J. Bulten, and F.C. Sweep Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding Am J Pathol 171 2007 1324 1333
11. C. Ricciardelli, D.I. Quinn, W.A. Raymond, K. McCaul, P.D. Sutherland, and P.D. Stricker Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer Cancer Res 59 1999 2324 2328
12. A.D. Theocharis, M.E. Tsara, N. Papageorgacopoulou, D.D. Karavias, and D.A. Theocharis Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition Biochim Biophys Acta 1502 2000 201 206
13. S. Ghosh, L. Albitar, R. LeBaron, W.R. Welch, G. Samimi, and M.J. Birrer Up-regulation of stromal versican expression in advanced stage serous ovarian cancer Gynecol Oncol 119 2010 114 120
14. K. Voutilainen, M. Anttila, S. Sillanpaa, R. Tammi, M. Tammi, and S. Saarikoski Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis Int J Cancer 107 2003 359 364
15. P. Pothacharoen, S. Siriaunkgul, S. Ong-Chai, J. Supabandhu, P. Kumja, and C. Wanaphirak Raised serum chondroitin sulfate epitope level in ovarian epithelial cancer J Biochem 140 2006 517 524
16. K.S. Anderson, J. Wong, A. Vitonis, C.P. Crum, P.M. Sluss, and J. Labaer p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer Cancer Epidemiol Biomarkers Prev 19 2010 859 868
17. H. Blegen, N. Einhorn, K. Sjovall, A. Roschke, B.M. Ghadimi, and L.M. McShane Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas Int J Gynecol Cancer 10 2000 477 487
18. M. Kobel, S.E. Kalloger, N. Boyd, S. McKinney, E. Mehl, and C. Palmer Ovarian carcinoma subtypes are different diseases: implications for biomarker studies PLoS Med 5 2008 e232
19. K. Munstedt, G.R. von, and F.E. Franke Correlation between MIB1-determined tumor growth fraction and incidence of tumor recurrence in early ovarian carcinomas Cancer Invest 22 2004 185 194
20. M. Olivier, M. Hollstein, and P. Hainaut TP53 mutations in human cancers: origins, consequences, and clinical use Cold Spring Harb Perspect Biol 2 2010 a001008
21. J.D. Seidman, P. Russell, and R.J. Kurman Surface epithelial tumors of the ovary R.J. Kurman, R.W. TeLinde, Blaustein's pathology of the female genital tract Fifth ed. 2002 Springer New York 791 904
22. M. Kobel, A. Reuss, A. Bois, S. Kommoss, F. Kommoss, and D. Gao The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas J Pathol 222 2010 191 198
23. M. Polcher, N. Friedrichs, C. Rudlowski, R. Fimmers, M. Keyver-Paik, and K. Kubler Changes in Ki-67 labeling indices during neoadjuvant chemotherapy for advanced ovarian cancer are associated with survival Int J Gynecol Cancer 20 2010 555 560
24. P. Morice, C. Uzan, R. Fauvet, S. Gouy, P. Duvillard, and E. Darai Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence Lancet Oncol 13 2012 e103 e115
25. J.D. Seidman, P. Russell, and R.J. Kurman Surface epithelial tumor of the ovary R.J. Kurman, Blaustein's pathology of the female genital tract 2002 Springer New York 791 904
26. D. Ohlund, C. Lundin, B. Ardnor, M. Oman, P. Naredi, and M. Sund Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer Br J Cancer 101 2009 91 97
27. J. Paulsson, T. Sjoblom, P. Micke, F. Ponten, G. Landberg, and C.H. Heldin Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer Am J Pathol 175 2009 334 341
28. T. Gambichler, A. Kreuter, S. Grothe, P. Altmeyer, N.H. Brockmeyer, and S. Rotterdam Versican overexpression in cutaneous malignant melanoma Eur J Med Res 13 2008 500 504
29. R. Pirinen, T. Leinonen, J. Bohm, R. Johansson, K. Ropponen, and E. Kumpulainen Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis Hum Pathol 36 2005 44 50
30. S. Suwiwat, C. Ricciardelli, R. Tammi, M. Tammi, P. Auvinen, and V.M. Kosma Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer Clin Cancer Res 10 2004 2491 2498
31. S.S. Deepa, Y. Umehara, S. Higashiyama, N. Itoh, and K. Sugahara Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues J Biol Chem 277 2002 43707 43716
32. Y. Wegrowski, and F.X. Maquart Chondroitin sulfate proteoglycans in tumor progression Adv Pharmacol 53 2006 297 321
33. Murugan S. Basappa, K.N. Sugahara, C.M. Lee, G.B. Ten Dam, T.H. van Kuppevelt, and M. Miyasaka Involvement of chondroitin sulfate E in the liver tumor focal formation of murine osteosarcoma cells Glycobiology 19 2009 735 742
34. F. Li, G.B. Ten Dam, S. Murugan, S. Yamada, T. Hashiguchi, and S. Mizumoto Involvement of highly sulfated chondroitin sulfate in the metastasis of the Lewis lung carcinoma cells J Biol Chem 283 2008 34294 34304